Inactive Instrument

Avista Public Acquisition Corp. II Stock

Equities

OABIV

KYG072471025

Dynamic Chart
Avista Public Acquisition Corp. II Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Avista Public Acquisition Corp. II(NasdaqCM:AHPA) dropped from NASDAQ Composite Index CI
OmniAb, Inc. completed the acquisition of Avista Public Acquisition Corp. II from Avista Capital Holdings, L.P., Polar Asset Management Partners Inc., Citadel Advisors LLC, HGC Investment Management Inc., Beryl Capital Management LLC and others. CI
Avista Public Acquisition Corp. II Announces Board and Committee Changes CI
Avista Public Acquisition Corp. II Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Avista Public Acquisition Corp. II Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Avista Public Acquisition Corp. II Reports Earnings Results for the Eleven Months Ended December 31, 2021 CI
Ligand Pharmaceuticals to Spin Off OmniAb Business Via Merger With Avista Public Acquisition MT
Ligand Pharmaceuticals Incorporated and Avista Public Acquisition Corp. II Announces Executive Changes CI
OmniAb, Inc. entered into a initial draft of a non-binding letter of intent to acquire Avista Public Acquisition Corp. II for $850 million. CI
Avista Public Acquisition Corp. II announced that it has received $0.75 million in funding from Avista Acquisition LP II CI
Certain Class B Ordinary Shares of Avista Public Acquisition Corp. II are subject to a Lock-Up Agreement Ending on 5-FEB-2022. CI
Avista Public Acquisition Corp. II(NasdaqCM:AHPA) added to NASDAQ Composite Index CI
Avista Public Acquisition Corp. II has completed an IPO in the amount of $200 million. CI
Avista Public Acquisition Corp. II has filed an IPO in the amount of $200 million. CI
More news
Avista Public Acquisition Corp. II (APAC) is a blank check company. The Company was formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company intends to focus in the healthcare industry. The Company has not commenced any operations nor generated any revenues.
Sector
-
More about the company